What the business is, and whether it's a good one at a fair price.
Distills potable spirits and ethanol, and manufactures bio-based chemicals across four reporting segments. Potable Spirits is the largest at ₹6,946.43 crore (70.7% of FY26 segment revenue, EBIT ₹284.93 crore), producing Indian-made brands including Bunty Bubbly, described by management as India's largest-selling spirit brand, with Indian-made foreign liquor (IMFL) now about 31% of segment revenue versus mid-teens earlier. Bio-Fuel contributed ₹1,469.93 crore (15.0%, EBIT ₹115.23 crore), supplying ethanol under India's blending programme — the 20% blending target was achieved ahead of the 2030 schedule. Bio-based Specialities and Performance Chemicals made ₹1,202.5 crore (12.2%, EBIT ₹140.95 crore) at 11.7% margin, conducted partly through a Clariant joint venture from which a further 24% stake sale is planned in FY28-29. Ennature Biopharma is the smallest at ₹207.77 crore (2.1%, EBIT ₹7.23 crore). NCLT Allahabad has sanctioned a Scheme of Arrangement demerging the Bio Pharma undertaking into Ennature Bio Pharma Limited and the Spirits and Biofuel undertaking into IGL Spirits Limited, with appointed date 1 April 2026. The largest cost line in FY26 was other operating expenses at 65.0% of revenue, followed by materials at 24.5%, capex-related spend at 8.4%, depreciation at 1.6% and employees at 1.3%.
Measured from the filed financials, judged against its Breweries & Distilleries peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from INDIA GLYCOLS LTD's filed financials and exchange disclosures
INDIA GLYCOLS LTD is a Beverages company listed on NSE and BSE, trading under the symbol INDIAGLYCO.
Yes. Over the trailing twelve months INDIA GLYCOLS LTD reported a net profit of ₹316 Cr on revenue of ₹10,312 Cr.
Yes. The dividend yield is 3.81% at the current price. It paid out 26% of its profit as dividend in FY26.
No. Debt stands at 0.54× equity, and it carries net debt of ₹1,547 Cr. That is lower than 46% of its 25 Breweries & Distilleries peers.
On trailing P/E, INDIA GLYCOLS LTD ranks 5 of 24 in Breweries & Distilleries — cheaper than 83% of them, against an industry median of 23.8×. This is a position, not a valuation judgement.
On a typical session INDIA GLYCOLS LTD moves 1.29% — that is the median absolute close-to-close move across its last 268 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by INDIA GLYCOLS LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
